GSK Lunch Symposium
B Cell Therapies for Lupus Nephritis & Herpes Zoster Vaccination in Immunocompromised Population
Dr. Wen-Nan Huang (Taiwan, China)
Novo Nordisk Lunch Symposium
Break
Opening Ceremony
David Todd Distinguished Lecture
Leveraging China’s Rapid Growth in Medicine and Health
Prof. Chak-Sing Lau (Hong Kong, China)
Session 1 - Future Diagnostics & Therapeutics
Novel Drug Delivery and Nano-medicine
Prof. Khuloud Al-Jamal (Hong Kong, China)
From Theory to Practice: Optimizing the Use of Biomarkers in the Alzheimer's Disease Patient Journey
Dr. Craig Ritchie (United Kingdom)
Coffee Break
Richard Yu Lecture
The Next Pandemic: Forecasting, Fear, and Readiness
Prof. Ivan Hung (Hong Kong, China)
Session 2 - Infectious Diseases & Prevention
Novel Vaccine Platforms for Prevention of Respiratory Viral Infection
Prof. Raven Kok (Hong Kong, China)
Interactive Workshop I
Rethinking Guidelines Beyond BMI: The Role of GIP+GLP-1 RA in Addressing the Pathophysiology of Obesity
Prof. Thomas Ebert (Germany)
Practical Tips in Diabetes Mellitus: Continuous Glucose Monitoring and Medication Titration
Dr. Chariene Woo (Hong Kong, China)
Session 3 - Haematology & Medical Oncology
Hematological, Cardiovascular and Aging-Related Implications of Clonal Hematopoiesis
Dr. Min-Han Tan (Singapore)
Coffee Break
Session 4 - Cardiovascular-Kidney-Metabolic Health
Advancing CKD Management: Expanding Protection for a Broader Patient Population
Prof. Takashi Yokoo (Japan)
Latest Advances in the Diagnosis and Management of TTR Amyloidosis
Prof. Hung-Fat Tse (Hong Kong, China)
Current Challenges in LDL-C Control and New Therapeutic Options: Insights from European Registries
Prof. Alberico Catapano (Italy)
Lunch Break
Boehringer Ingelheim Lunch Symposium
The Evolving HF Management Map: Strategies Across LVEF and the Treatment Course
Prof. Theresa McDonagh (United Kingdom)
Bayer Lunch Symposium
Management of Cardio-Renal-Metabolic Conditions: What, Why and How?
Prof. Shelley Zieroth (Canada)
Session 5 - Nephrology
Addressing the Calcium-Phosphorus Product and Cardiovascular Risk in Dialysis Patients
Prof. Emilio Sánchez (Spain)
Optimizing Advanced Therapy in IgA Nephropathy: Clinical Strategies and Considerations
Prof. Hong Zhang (Beijing, China)
A Milestone in ADPKD Management: from Clinical Settings to Local Society
Prof. Yong-Chul Kim (South Korea)
Coffee Break
Session 6 - Respiratory Medicine
Precision Medicine in Severe Type 2 Asthma
Prof. James Ho (Hong Kong, China)
Strengthening COPD Stability: Starting with Exacerbation Prevention Through Optimal SITT
Prof. Kay-Choong See (Singapore)
Optimizing COPD Management: The Role of Dual Bronchodilation Amidst Evolving Therapeutic Options
Prof. Herbert Kwok (Hong Kong, China)
Closing Remarks
Interactive Workshop II
Skin Tests and Allergy De-labelling
Dr. Jane Wong (Hong Kong, China)
From Law to Bedside: Implementing Hong Kong’s New Advance Medical Directive Legislation in Clinical Practice
Prof. Jacqueline Yuen (Hong Kong, China)
Session 7 - Health in Women & Elderly
Integrating Fezolinetant into VMS Treatment Landscape: Clinical Integration Strategies for Diverse Patient Needs
Dr. Natassia Rodrigo (Australia)
Anabolic Therapies: Unmatched Gains in BMD in Osteoporosis Treatment
Prof. Charles Inderjeeth (Australia)
Coffee Break
Session 8 - Neurology
Revolutionising Acute Ischemic Stroke Care: The 30-Year Journey and Beyond
Prof. Gary Lau (Hong Kong, China)
Lunch Break
AstraZeneca Lunch Symposium 1
Navigating the CKD Journey - Prevent CKD Progression & Managing CKD Anaemia
Prof. David Wheeler (United Kingdom)
AstraZeneca Lunch Symposium 2
Chronic Airway Management: Cough-Variant Asthma and At-Risk COPD
Prof. Jennifer Quint (United Kingdom)
Session 9 - Gastroenterology & Hepatology
Non-Variceal Upper Gastrointestinal Bleeding: A 2026 Update
Prof. Alan Barkun (Canada)
Functional Cure in Chronic Hepatitis B Management
Prof. Loey Mak (Hong Kong, China)
The Impact of Gastric Acid Control on Helicobacter pylori Eradication Success
Prof. Takashi Kawai (Japan)
Coffee Break
Session 10 - Dermatology, Rheumatology & Clinical Immunology
Vitiligo – Advancing Treatment Strategies and Outcomes
Dr. Johnny Chan (Hong Kong, China)
Identifying High-risk-to-progress Psoriatic Disease Phenotypes and Strategies to Prevent Disease Progression
Dr. Martin Chung (Hong Kong, China)
Empowering Primary Care in Atopic Dermatitis: The Role of Next-Generation Biologics in Long-Term Disease Control
Prof. Philip Li (Hong Kong, China)